PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cholesterol drug may have role in treating prostate cancer

Crestor suppressed human cancer cells transplanted to mice

2010-09-20
(Press-News.org) TORONTO, Ont., Sept. 20, 2010 – A drug commonly prescribed for people with high cholesterol may also be effective in treating prostate cancer, according to new research by Dr. Xiao-Yan Wen at St. Michael's Hospital.

Rosuvastatin—a statin drug sold as Crestor—suppressed the growth of transplanted human prostate cancer cells in mice.

"Our data provided solid pre-clinical evidence and a strong rationale for clinical trials of statins in the treatment of prostate cancer," said Wen, whose research appears in the September issue of European Urology, the journal of the European Association of Urology.

Prostate cancer is the most common cancer in Canadian men – one in seven men will develop the disease during his lifetime and one in 27 will die from it. Despite improvements in treatments such as surgery, radiation and chemotherapy, many patients still progress to advanced stages.

Recent clinical trials have shown encouraging results regarding the use of angiogenic inhibitors—substances that prevent the growth of blood vessels that feed tumors.

Wen and his colleagues in Canada and China screened 2,000 small molecules in zebrafish embryos with 2,000 small molecules. Seven compounds—four of them statins—slowed or prevented the growth of those blood vessels. They then decided to investigate the cancer-fighting potential of one of those statins, rosuvastatin, and found it suppressed the growth of prostate cancer in mice without apparent side effects.

If human trials confirmed that statin drugs can optimize the benefits of radiation, that would help doctors determine the most effective, less toxic and affordable treatments for their prostate cancer patients.

INFORMATION:

About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The Hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care and care of the homeless are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing Knowledge Institute, research at St. Michael's Hospital is recognized and put into practice around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

For more information, please contact:

Leslie Shepherd
Senior Public Relations Specialist
St. Michael's Hospital
Phone: 416-864-6094 or 647-300-1753
www.stmichaelshospital.com

END



ELSE PRESS RELEASES FROM THIS DATE:

Study: Privacy key obstacle to adopting electronic health records

2010-09-20
The United States could achieve significant health care savings if it achieved widespread adoption of electronic health records (EHRs), but insufficient privacy protections are hindering public acceptance of the EHR concept, according to a new paper from researchers from North Carolina State University. The paper outlines steps that could be taken to boost privacy and promote the use of EHRs. "Electronic health records could reduce costs in the U.S. by an estimated $80 to 100 billion each year," says Dr. David Baumer, head of the business management department at NC State ...

Kids and diabetes risk: Do chromosomes hold new clues?

2010-09-20
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health. Butte is with the USDA Agricultural Research Service (ARS) Children's Nutrition Research Center at Baylor College of Medicine in Houston, Texas, where she is a professor of pediatrics. ARS is USDA's principal ...

Plague researchers race to beat bioterrorists

Plague researchers race to beat bioterrorists
2010-09-20
Saranac Lake, N.Y. – Given the many pressing concerns of the day, fear of plague probably isn't what causes most Americans to lose sleep. But for those whose responsibility it is to combat bioterrorism, plague is among the highest priorities. Those charged with that mission include scientists like medical researcher Steve Smiley, whose lab at the Trudeau Institute is working to develop a vaccine that will protect the public against weaponized forms of plague. The Institute, which is dedicated to studying how the immune system responds to infectious diseases, is at the forefront ...

No pain in the hospital -- wishful thinking or reality?

2010-09-20
More than 80% of hospitalized patients suffer more severe pain than necessary. This is the conclusion of Christoph Maier (Bochum University Hospital, Bochum, Germany) and his coauthors in their interim report of the Pain-Free Hospital Project ("Schmerzfreies Krankenhaus"), which appears in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[36]: 607-14). The project, which was initiated in 2003, has the goal of improving pain management in hospitals across Germany. To study the quality of pain therapy, the authors evaluated anonymous ...

Fidgety children are on the rise

2010-09-20
Hyperkinetic disorders among children and adolescents are becoming increasingly common. In the current issue of Deutsches Ärzteblatt International, Ingrid Schubert of the PMV Research Group at the University of Cologne and her colleagues address the question how this has affected the frequency of prescriptions for methylphenidate, a stimulant drug that is used to treat such disorders (Dtsch Arztebl Int 2010; 107[36]: 615¬21). The authors analyzed data concerning tens of thousands of persons insured by the AOK health insurance company in the German state of Hesse over the ...

Effects of chemoradiation therapy by using capecitabine on gastric cancer patients

2010-09-20
Gastric cancer is a major cause of cancer deaths in the world. The outcome of large gastric tumors and those with lymph node involvement remains poor after surgical resection. The optimal adjuvant therapy after surgical resection remains to be determined. The most common strategies in the adjuvant treatment of gastric cancers include fluoropyrimidine-based chemotherapy with or without radiation. The introduction of capecitabine has largely replaced continuous-infusion 5-fluorouracil (5-FU) owing to its ease of administration. However, its efficacy is not proven in randomized ...

How to control massive bleeding from the hepatic artery

2010-09-20
Delayed hepatic arterial hemorrhage after pancreaticoduodenectomy (PD) is not a common but a fatal complication, occurring in 7% of all patients. Its ideal management remains unclear and controversial. A research article published on August 7, 2010 in the World Journal of Gastroenterology addresses this question. The authors reported the clinical outcome of 9 patients with life-threatening hemorrhage from a ruptured hepatic artery pseudoaneurysm after PD after treatment with a new interventional technique, namely placement of stent-grafts. This technique provides a good ...

New options for enteral nutrition in patients with severe acute pancreatitis

2010-09-20
Severe acute pancreatitis (SAP) requires an adequate nutritional support. Enteral nutrition (EN) should be preferred to total parenteral nutrition in patients with SAP, as it is associated with reduced mortality and complications. However, in clinical practice EN is employed far less frequently than it should. The main obstacle to EN diffusion is that it is considered complicated, as to ensure full pancreatic rest, nutrition tubes should be placed in the jejunum, requiring often troublesome procedures. In the past few years, it has been proposed that EN through nasogastric ...

Serious hockey injuries among young children skyrocketing, study finds

2010-09-20
COLUMBUS, Ohio – The incidence of hockey-related injuries among children aged 9 to 14 leading to emergency department visits more than doubled between 1990 and 2006, according to a new nationwide study. There were 2,935 hockey injuries treated in emergency departments in that age group in 1990, increasing to 7,713 in 2006 – an increase of 163 percent. The injury incidence among teens aged 15 to 18 didn't increase as much as that of younger children, but still grew 85 percent during the same time period. The startling increase in injuries calls for more attention to ...

U of M research shows US teen hearing loss is much lower than has been widely reported

2010-09-20
New research from University of Minnesota hearing scientists shows that fewer than 20 percent of teenagers in the United States have a hearing loss as a result of exposure to loud sounds, thus offering a different analysis of data reported in the Journal of the American Medical Association (JAMA) in August. The U of M's research, forthcoming in the Journal of Speech, Language, and Hearing Research, points out that the small hearing losses that audiologist are trying to identify with conventional hearing tests are subject to measurement error and that as many as 10 percent ...

LAST 30 PRESS RELEASES:

Scientists trace microplastics in fertilizer from fields to the beach

The Lancet Obstetrics, Gynecology, & Women’s Health: Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities, confirms new gold-standard evidence review

Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities

Harm reduction vending machines in New York State expand access to overdose treatment and drug test strips, UB studies confirm

University of Phoenix releases white paper on Credit for Prior Learning as a catalyst for internal mobility and retention

Canada losing track of salmon health as climate and industrial threats mount

Molecular sieve-confined Pt-FeOx catalysts achieve highly efficient reversible hydrogen cycle of methylcyclohexane-toluene

Investment in farm productivity tools key to reducing greenhouse gas

New review highlights electrochemical pathways to recover uranium from wastewater and seawater

Hidden pollutants in shale gas development raise environmental concerns, new review finds

Discarded cigarette butts transformed into high performance energy storage materials

Researchers highlight role of alternative RNA splicing in schizophrenia

NTU Singapore scientists find new way to disarm antibiotic-resistant bacteria and restore healing in chronic wounds

Research suggests nationwide racial bias in media reporting on gun violence

Revealing the cell’s nanocourier at work

Health impacts of nursing home staffing

Public views about opioid overdose and people with opioid use disorder

Age-related changes in sperm DNA may play a role in autism risk

Ambitious model fails to explain near-death experiences, experts say

Multifaceted effects of inward foreign direct investment on new venture creation

Exploring mutations that spontaneously switch on a key brain cell receptor

Two-step genome editing enables the creation of full-length humanized mouse models

Pusan National University researchers develop light-activated tissue adhesive patch for rapid, watertight neurosurgical sealing

Study finds so-called super agers tend to have at least two key genetic advantages

Brain stimulation device cleared for ADHD in the US is overall safe but ineffective

Scientists discover natural ‘brake’ that could stop harmful inflammation

Tougher solid electrolyte advances long-sought lithium metal batteries

Experts provide policy roadmap to reduce dementia risk

New 3D imaging system could address limitations of MRI, CT and ultrasound

First-in-human drug trial lowers high blood fats

[Press-News.org] Cholesterol drug may have role in treating prostate cancer
Crestor suppressed human cancer cells transplanted to mice